Latest updates for Bmy

Fresh curated links around BMY are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Bristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
  • Bristol-Myers Squibb: Cash Flow Machine, Outsized Growth Portfolio, And Inflation Beating Incomes
  • Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /1 month ago

Bristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Read source
seekingalpha.com /1 week ago

Bristol-Myers Squibb: Cash Flow Machine, Outsized Growth Portfolio, And Inflation Beating Incomes

Read source
fool.com /2 weeks ago

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Bristol Myers Squibb leans on specialty medicines and a discounted valuation, while Johnson & Johnson boasts industry-leading margins and cash flow.

Read source
finance.yahoo.com /1 month ago

Biomarin Pharmaceutical (BMRN): Most Undervalued Stocks to Buy and Hold for 2 Years

Read source
pharmexec.com /1 month ago

<![CDATA[Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand St...

Read source
cafepharma.com /6 days ago

BMS layoffs 2026

BMS layoffs 2026 Anonymous (not verified) Thu, 07/09/2026 - 09:10 field_thread_url https://cafepharma.com/boards/threads/bms-layoffs-2026.713612/...

Read source
cafepharma.com /1 week ago

BMS layoffs 2026

BMS layoffs 2026 Anonymous (not verified) Wed, 07/08/2026 - 09:09 field_thread_url https://cafepharma.com/boards/threads/bms-layoffs-2026.713612/...

Read source
fool.com /1 month ago

Why Bristol Myers Squibb Stock Isn't Nearly As Cheap As It Looks

Bristol Myers Squibb has an attractive 4.4% yield, and its 16x P/E is below the pharma average of 24x.

Read source
finance.yahoo.com /1 month ago

Market Update: MDT

Read source
seekingalpha.com /1 month ago

B&M European Value Retail plc 2026 Q4 - Results - Earnings Call Presentation

Read source
cafepharma.com /3 days ago

BMS SUCKS!!!

BMS SUCKS!!! Anonymous (not verified) Sun, 07/12/2026 - 12:13 field_thread_url https://cafepharma.com/boards/threads/bms-sucks.660695/ b...

Read source
fool.com /1 month ago

How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.

Bristol Myers Squibb has a well-above-market yield of 4.5% and it appears reasonably safe.

Read source
seekingalpha.com /2 weeks ago

British American Tobacco: Not Simply Philip Morris' Lagging Sibling

Read source
finance.yahoo.com /1 month ago

BitMine Immersion (BMNR) Reports $9.6B Crypto and Cash Holdings, Led by Ethereum Treasury

Read source
qchron.com /3 weeks ago

Bitmine Immersion Technologies Announces Cash Dividend of $0.1056 per Share of 9.50% Series A Perpetual Preferred Stock

NORWALK, Conn., June 18, 2026 /PRNewswire/ -- (NYSE: BMNR; BMNP) Bitmine Immersion Technologies, Inc. ("Bitmine" or the "Company") announced today that its Board of Directors has d...

Read source
seekingalpha.com /1 month ago

BNY Mellon Opportunistic Municipal Securities Fund Q1 2026 Commentary

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Bmy

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

finance.yahoo.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source

pharmexec.com

Recent coverage from public sources
Public source